awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q34658095-475AB177-44FD-459F-A03A-F92A70B2CE36
Q34658095-475AB177-44FD-459F-A03A-F92A70B2CE36
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34658095-475AB177-44FD-459F-A03A-F92A70B2CE36
Randomized phase III trial of temsirolimus versus sorafenib as second-line therapy after sunitinib in patients with metastatic renal cell carcinoma.
P2860
Q34658095-475AB177-44FD-459F-A03A-F92A70B2CE36
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34658095-475AB177-44FD-459F-A03A-F92A70B2CE36
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
14fe2cbe4876dccf62dcc41d925399954149a65f
P2860
Comparative effectiveness of axitinib versus sorafenib in advanced renal cell carcinoma (AXIS): a randomised phase 3 trial.